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Background: Tuberculosis (TB) is a major health problem, and accurate and rapid diagnosis of multidrug-resistant 
(MDR) and extended drug-resistant (XDR) TB is important for appropriate treatment. In this study, performances of solid 
and liquid culture methods were compared with respect to MDR- and XDR-TB isolate recovery and drug susceptibility 
testing.
Methods: Sputum specimens from 304 patients were stained with Ziehl-Neelsen method. Mycobacterium tuberculosis 
(Mtb) isolates were tested for recovery on Löwenstein-Jensen (LJ) medium and the BacT Alert 3D system. For drug 
susceptibility testing of Mtb, isolates were evaluated on M-KIT plates and the BacT Alert 3D system.
Results: The recovery rates were 94.9% (206/217) and 98.2% (213/217) for LJ medium and the BacT Alert 3D system, 
respectively (kappa coefficient, 0.884). The rate of drug resistance was 13.4% for at least one or more drugs, 6.0% for 
MDR-TB and 2.3% for XDR-TB. M-KIT plate and BacT 3D Alert 3D system were comparable in drug susceptibility testing 
for isoniazid (97.7%; kappa coefficient, 0.905) and rifampin (98.6%; kappa coefficient, 0.907). Antibiotic resistance was 
observed using M-KIT plates for 24 of the total 29 Mtb isolates (82.8%).
Conclusion: The liquid culture system showed greater reduction in the culture period, as compared with LJ medium; 
however, drug susceptibility testing using M-KIT plates was advantageous for simultaneous testing against multiple drug 
targets.
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Introduction
Tuberculosis (TB) is a major public health problem, with 8.6 
million new cases and 1.3 million deaths per year1. Multidrug-
resistant (MDR)-TB is defined as TB resistant to at least iso-
niazid (INH) and rifampin (RIF), and extended drug-resistant 
(XDR)-TB is TB caused by MDR plus any fluoroquinolone 
(FQ) and at least one of the injectable second-line drugs, 
such as amikacin (AMK), kanamycin (KM), or capreomycin2. 
MDR-TB and XDR-TB are major challenges for TB control 
worldwide and are of great concern because they are difficult 
to cure with existing drugs and are associated with high mor-
tality2,3. The estimated global burden of MDR-TB is 450,000, 
and 3.6% of all new TB cases and more than 20% of those with 
a previous history of TB treatment are MDR-TB1. In South Af-
rica, 1.8% of new cases and 6.7% of those with a previous his-
tory of TB treatment were MDR-TB1. On the other hand, 32.2% 
of new cases and 75.6% of those with a previous history of TB 
treatment were MDR-TB in Belarus4. The percentage of XDR-
TB cases among MDR-TB cases was 9.6%, and XDR-TB cases 
were reported in 92 countries by the end of 20121. The high 
proportion of XDR-TB among MDR-TB cases was reported in 
Azerbaijan (Baku City, 12.8%), Belarus (11.9%), Latvia (16%), 
Lithuania (24.8%), and Tajikistan (21.0%)1.
Early diagnosis of MDR-TB or XDR-TB is essential for the 
treatment and prevention of transmission. Laboratory diag-
nosis of TB depends on microscopic examination of sputum 
stained for acid-fast bacilli (AFB) and on the culture of spu-
tum5. The appearance of drug-resistant TB requires isolation 
of Mycobacterium tuberculosis  (Mtb) and drug susceptibility 
testing, which are now recommended for all new pulmonary 
TB patients in response to the emergence of MDR- and XDR-
TB6.
Mycobacterial culture and drug susceptibility testing have 
been performed using solid egg- or agar-based medium in 
many countries, including Korea, because they are inexpen-
sive and can be performed easily7. However, these methods 
require long periods to yield results8. The liquid medium 
culture method has been utilized to reduce the culture period 
of Mtb. Several studies have demonstrated that the liquid me-
dium culture method is superior to the solid medium culture 
method, yielding quicker results and more mycobacterial 
isolates9. The World Health Organization recommends the 
adoption of mycobacterial culture and drug susceptibility test-
ing using liquid culture systems10. Automated liquid culture 
systems, such as the MGIT 960 system (Becton Dickinson, 
Sparks, MD, USA), have been adopted in many countries and 
used in routine diagnosis in many diagnostic laboratories in 
Korea10. Drug susceptibility testing using the automated liquid 
culture system is possible for first-line drugs11, but methods 
have yet to be established for second-line drugs for the diag-
nosis of MDR-TB and XDR-TB. 
There have been few studies comparing the performance 
of solid and liquid culture methods for mycobacterial culture 
and drug susceptibility testing in high-burden MDR-TB and 
XDR-TB cases. In Korea, 2.7%–3.9% of new cases and 14.0%–
27.2% of those with a previous history of TB treatment were 
MDR-TB10,12.
In the present study, the performances of solid and liquid 
culture methods for mycobacterial culture and drug suscep-
tibility testing were compared in the high burden setting of 
MDR-TB and XDR-TB cases in National Masan Tuberculosis 
Hospital in Korea. This is the largest dedicated TB national 
tertiary hospital in the public sector of Korea and has been re-
sponsible for the management of MDR-TB and XDR-TB cases. 
Materials and Methods
1. Study sites and subjects
The study was performed at the National Masan Tuberculo-
sis Hospital, a referral TB hospital in Korea focusing especially 
on MDR-TB management, and at the International Tubercu-
losis Research Institute, Masan, Korea. Sputum specimens 
were obtained from subjects visiting the National Masan Tu-
berculosis Hospital between April 2009 and June 2011. New 
and previously treated TB cases were enrolled in this study. 
The inclusion criteria resulted in the enrollment of adults 20 
years of age or older who had clinical signs or symptoms sug-
gestive of TB. All subjects provided written informed consent 
to participate, and the study was approved by the Institutional 
Ethics Committee of National Masan Tuberculosis Hospital. 
2. Specimen processing and AFB smear
Sputum specimens were decontaminated in an equal 
volume of N-acetyl-L-cysteine–3% sodium hydroxide citrate 
(final NaOH concentration was 1.5%) for 15 minutes at room 
temperature. After decontamination, the specimens were 
neutralized using sterile phosphate-buffered saline (PBS, pH 
6.8) and centrifuged at 3,000 ×g for 20 minutes. After decant-
ing the supernatant, the pellet was suspended in sterile PBS 
(pH 6.8) and used for smear preparation and inoculation into 
both Löwenstein-Jensen (LJ) medium (Union Lab., Seoul, Ko-
rea) and the BacT Alert 3D system (BioMérieux, Saint-Vulbas, 
France).
Smears were prepared using the suspended pellet and 
stained by the Ziehl-Neelsen method. The presence of AFB 
was examined using a light microscope, and the results of the 
AFB smears were graded according to the American Thoracic 
Society/Center for Disease Control and Prevention as follows: 
grade 0, no bacilli in 399 fields; trace, 1–2 bacilli in 300 fields; 
grade 1, 1–9 bacilli in 100 fields; grade 2, 1–9 bacilli in 10 fields; 
grade 3, 1–9 bacilli in 1 field; and grade 4, > 9 bacilli in 1 field13. 
Smears were recorded as positive if at least 10 AFB per 100 
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fields were observed according to the guidelines.
3. Mycobacterial culture 
Mycobacteria was cultured according to the Clinical and 
Laboratory Standards Institute guidelines (2003)14 and the 
World Health Organization (2007)10. Following decontamina-
tion and sedimentation, sputum specimens were subjected to 
LJ media and the BacT Alert 3D system, an automatic liquid 
culture system for continuous monitoring of mycobacterial 
growth. Mycobacterial growth on LJ media was checked twice 
a week for 8 weeks. The time to detection was calculated as 
the time from the date of inoculation to the earliest date of vis-
ible colonies. 
The BacT Alert 3D system, an automated liquid culture 
system for continuous monitoring of mycobacterial growth, 
was used for mycobacterial culture from sputum specimens. 
Aliquots of 500 μL specimen suspensions were inoculated 
into mycobacterial culture tubes containing modified Middle-
brook 7H9 with an antibiotic supplement (amphotericin B, 
nalidixic acid, trimethoprim, polymyxin B, and vancomycin). 
Mycobacterial culture tubes were incubated at 37oC in the 
BacT Alert 3D system for up to 40 days. Specimens were mon-
itored hourly for increases in the level of carbon dioxide by the 
BacT Alert 3D system, which gave audible and visible alerts 
for the presence of mycobacteria in the tubes. Time to detec-
tion was calculated as the time between the date of inocula-
tion and the earliest date that positive growth was recorded by 
the instrument.
4. Identification of mycobacteria 
All specimens identified as positive from any culture 
were examined by Ziehl-Neelsen staining and the SD TB Ag 
MPT64 rapid test (SD Inc., Youngin, Korea). DNA extraction 
was performed as described previously13. Briefly, three or four 
colonies grown on LJ slants were suspended in sterile distilled 
water. Suspended bacteria and mycobacterial cultures from 
the BacT Alert 3D system were heat-inactivated at 95oC for 
30 minutes. Cell debris was precipitated by centrifugation for 
2 minutes at 10,000 ×g, and the supernatant was used for the 
identification of Mtb and mycobacterial species. The DNA 
concentration was measured using the NanoDrop NT-1000 
spectrophotometer (Thermo Scientific, Wilmington, DE, 
USA). Identification of Mtb and species of mycobacterial spe-
cies was conducted using the Accuprobe Identification Test 
(Gen-Probe, San Diego, CA, USA), and REBA Myco-ID (M&D 
Inc., Wonju, Korea), according to the manufacturer’s instruc-
tions15.
5. Drug susceptibility testing 
Drug susceptibility testing was performed by the absolute 
concentration method with Mtb H37Rv as a reference using 
M-KIT plates (The Korean Institute of Tuberculosis, Osong, 
Korea) containing 10 anti-mycobacterial drugs. The critical 
concentrations of INH, RIF, ethambutol (EMB), KM, tuberlac-
tin, ethionamide, cycloserine, para-aminosalicylic acid (PAS), 
ofloxacin, and streptomycin (SM) were 0.2, 40, 2.0, 30, 40, 40, 
30, 1.0, 2.0, and 4.0 μg/mL, respectively14. Pyrazinamide (PZA) 
resistance was determined by the PZA test (PZA concentra-
tion, 50 μg/mL).
Drug susceptibility testing using the BacT Alert 3D system 
was conducted for INH and RIF. The drug concentrations 
used for the BacT Alert 3D system were 1.0 μg/mL for INH 
and 1.0 μg/mL for RIF. Mtb isolates showing inconsistent re-
sults were subjected to an additional drug susceptibility test.
6. Statistical analysis
Statistical analysis was performed using the GraphPad 
Prism program version 5.0 (GraphPad Software, La Jolla, CA, 
USA). Categorical variables were analyzed using the Pearson’s 
chi-square test or Fisher exact test and continuous variables 
were analyzed using the t test. A Wilcoxon test for paired 
samples was used to compare medians of the time to detec-
tion. A kappa correlation statistical analysis was performed to 
assess concordance of the results from both techniques. In all 
analyses, p<0.05 was taken to indicate statistical significance.
Results
1. AFB smears
Sputum specimens collected from 304 patients who visited 
the National Tuberculosis Hospital were processed for detec-
tion of AFB. Of 304 sputum specimens, 210 (69.1%) were AFB 
smear-positive and 94 (30.9%) AFB smear-negative.
2. Recovery rates and identification of mycobacteria
Overall, the detection rates were 66.4% on LJ medium and 
70.4% in the BacT Alert 3D system (Table 1). In smear-positive 
specimens, detection rates were 90.9% and 94.3% on LJ me-
dium and in the BacT Alert 3D system, respectively (p=0.053). 
In the smear-negative specimens, the detection rate (17.0%) 
in the BacT Alert 3D system was higher than that (11.7%) on 
LJ medium, but this difference was not significant. Overall, the 
contamination rates were 3.6% and 4.6% for LJ medium and 
the BacT Alert 3D system, respectively; 3.3% of cultures were 
contaminated in both culture methods (Table 1). The contam-
ination rate was similar between AFB smear-positive and AFB 
smear-negative specimens on LJ medium, while the contami-
nation rate was slightly higher for AFB smear-negative than 
AFB-positive specimens in the BacT Alert 3D system, albeit 
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without statistical significance (p=0.377).
A total of 218 isolates were recovered by at least one culture 
method. Most of the isolates (99.5%) were determined as 
Mtb, and only one isolate was identified as Mycobacterium 
abscessus  (Table 2). Of 217 Mtb isolates, 206 (94.9%) were 
detected on LJ medium and 213 (98.2%) in the BacT Alert 3D 
system (p=0.11). On the other hand, four (1.8%) were detected 
only on LJ medium and 11 (5.1%) only in the BacT Alert 3D 
system. There was good concordance in the culture results 
between both culture methods, with an agreement rate of 
94.8% (kappa coefficient, 0.884; 95% confidence interval [CI], 
0.8269–0.9413).
3. Time to detection of mycobacterial culture and drug 
susceptibility testing
For the 217 Mtb isolates that grew on both LJ medium and 
in the BacT Alert 3D system, the median detection time for 
the latter was significantly less than that for former (p<0.001); 
14 days (interquartile range [IQR], 12–16) versus 24 days (IQR, 
2–28) for all Mtb isolates (Table 3). The detection time using 
the BacT Alert 3D system was significantly less than that using 
LJ medium for both AFB smear-negative and -positive speci-
mens (p<0.001 in both comparisons). The median reporting 
times of drug susceptibility testing were 10 (IQR, 8–12) days 
for the BacT Alert 3D system and 20 (IQR, 18–24) days for LJ 
medium (p<0.001).
4. Drug susceptibility
The results of drug susceptibility testing of the 217 Mtb iso-
lates for the four first-line drugs and seven second-line drugs 
using M-KIT plates and the BacT Alert 3D system are listed in 
Table 4. Of the 217 Mtb isolates, 29 (13.4%) were resistant to at 
least one or more drugs; four were mono-resistant (3 for INH 
and 1 for PAS), 13 were MDR (2 for INH and RIF; 2 for INH, 
RIF, and other second-line drugs; 1 for INH, RIF, and EMB; 3 
for INH, RIF, EMB, and the second-line drug SM; 2 for INH, RIF, 
PZA, and second-line drugs; and 3 for four first-line drugs, and 
other second-line drugs), and five were XDR (2 for INF, RIF, 
Table 3. Time for recovery of Mycobacterium tuberculosis isolates and drug susceptibility test on LJ medium and the BacT 
Alert 3D system
Variable LJ medium (day) BacT Alert 3D system (day) p-value
Culture AFB smear-negative 28 (14–32) 15 (13–17) <0.001
AFB smear-positive 24 (20–28) 14 (12–15) <0.001
Total 24 (21–28) 14 (12–16) <0.001
Drug susceptibility testing 20 (18–24) 10 (8–12) <0.001
LJ medium: Löwenstein-Jensen medium; AFB: acid-fast bacilli.
Table 1. Recovery rates on LJ medium and the BacT Alert 3D system based on AFB smear status
AFB smear No. of specimens
LJ medium BacT Alert 3D system
Positive Negative Contamination Positive Negative Contamination 
Negative 94 11 (11.7) 79 (84.0) 4 (4.3) 16 (17.0) 72 (76.6) 6 (6.4)
Positive 210* 191 (91.0) 11 (5.2) 7 (3.3) 198 (94.3) 3 (1.4) 8 (3.8)
Total 304* 202 (66.4) 90 (29.6) 11 (3.6) 214 (70.4) 75 (24.7) 14 (4.6)
Values are presented as number (%).
*One AFB smear-positive culture was observed, which was identified as Mycobacterium abscessus.
LJ medium: Löwenstein-Jensen medium; AFB: acid-fast bacilli.
Table 2. Culture results of sputum specimens on LJ medium and the BacT Alert 3D system
Variable
BacT Alert 3D system
Total
Positive Negative
LJ medium Positive 202 4 206
Negative 11 86 97
Total 213 90 303
LJ medium: Löwenstein-Jensen medium.
SC Kim et al.
286 Tuberc Respir Dis 2016;79:282-288 www.e-trd.org
and other second-line drugs; 2 for INH, RIF, EMB, and other 
second-line drugs; and 1 for four first-line drugs and other 
second-line drugs). 
Drug susceptibility testing on INH and RIF were performed 
with 217 Mtb isolates using the M-KIT plates and the BacT 
Alert 3D system (Table 5). Of these, 30 (13.8%) and 31 (14.3%) 
isolates showed resistance to INH on M-KIT plates and the 
BacT Alert 3D system, respectively. Further, 16 (7.4%) and 19 
(8.8%) isolates were identified as resistant to RIF by M-KIT 
plates and the BacT Alert 3D system, respectively. Two iso-
lates (0.9%) showed resistance to INH only on M-KIT plates, 
and three isolates (1.4%) showed resistance to INH only with 
the BacT Alert 3D system. Three isolates (1.4%) were resis-
tant to RIF in the BacT Alert 3D system alone, while no RIF-
resistant isolates were detected using M-KIT plates alone.
There was good concordance between the results of drug 
susceptibility testing using the two methods with an agree-
ment of 97.7% (kappa coefficient, 0.905; 95% CI, 0.822–0.987) 
for INH and 98.6% (kappa coefficient, 0.907; 95% CI, 0.802–
1.012) for RIF, respectively. 
Discussion
Early detection of drug resistance in Mtb is essential for 
appropriate treatment and prevention of transmission11. My-
cobacterial culture and drug susceptibility testing using solid 
medium are the standard methods due to their simple proce-
dures and economic feasibility. In addition, drug susceptibility 
testing against several anti-TB drugs can be performed simul-
taneously using M-KIT plates16. However, this method has a 
disadvantage in that it takes a long time to obtain results. To 
Table 4. Results of drug susceptibility testing of Mycobacterium tuberculosis isolates
First-line drug Second-line drug No. of strains
Fully susceptible (n=188) - - 188
Mono-resistance (n=4) INH - 3 
- PAS 1





INH, EMB PAS 1
PAS, SM 1
MDR (n=13) INH, RIF - 2
INH, RIF PAS, OFX 1
PAS, SM 1
INH, RIF, EMB - 1
INH, RIF, EMB SM 3
INH, RIF, PZA CS 1
KM, SM 1
INH, RIF, EMB, PZA OFX, SM 2
ETH, PAS 1
XDR (n=5) INH, RIF KM, ETH, PAS, OFX, SM 1
KM, CS, PAS, OFX, SM 1
INH, RIF, EMB PAS, OFX, SM 1
KM, ETH, CS, OFX 1
INH, RIF, EMB, PZA KM, ETH, PAS, OFX, SM 1
Total 217
INH: isoniazid; PAS: para -aminosalicylic acid; SM: streptomycin; OFX: ofloxacin; EMB: ethambutol; PZA: pyrazinamide; MDR: multidrug-
resistant; RIF: rifampin; CS: cycloserine; KM: kanamycin; XDR: extended drug-resistant; ETH: ethionamide.
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reduce the culture period of Mtb, liquid culture systems have 
been adopted and show superior performance in reducing 
the culture period compared with solid medium.
In the present study, we evaluated the performance of the 
BacT Alert 3D system, a liquid culture system, for mycobacte-
rial culture and drug susceptibility testing by comparison with 
mycobacterial culture using LJ medium and drug susceptibil-
ity testing with M-KIT plates in the situation of a high MDR-TB 
and XDR-TB burden. In our study population, the prevalences 
of MDR-TB and XDR-TB in our pool of isolates were 6.0% 
and 2.3%, respectively. These results were slightly different 
from those of Choi et al.12 who reported a rate of resistance 
to at least one or more drugs of 17.6%, with MDR-TB seen in 
3.9% of new cases and 27.2% of previously treated cases (8.5% 
in total) in a private referral center in Korea. In addition, the 
rate of XDR-TB was 0.8% in new cases and 4.0% in previously 
treated cases (1.4%). On the other hand, Bai et al.16 reported 
that the rate of resistance to at least one or more drugs was 
10.9%–12.8% and that of MDR-TB 1.6%–2.7% in a survey con-
ducted during 1994–2004 at 245 health centers in Korea14. 
These differences may be related to the study populations, i.e., 
the larger number of previously treated cases in the referral 
hospitals may have resulted in the higher rate of drug resis-
tance7. The study by Bai et al.16 was performed in public health 
centers, a public form of primary health care in Korea that 
cares mostly for new cases, while our study and that reported 
by Choi et al.12 were performed in a public referral TB hospital 
and a private referral medical center, respectively, in which the 
target population included more previously treated cases. 
The BacT Alert 3D system, a liquid culture system, detected 
the growth of Mtb at an earlier time point than did LJ culture 
medium (14 days vs. 24 days, respectively; p<0.001) as report-
ed previously9. The detection time was significantly reduced in 
the liquid culture system compared with LJ culture medium in 
both AFB smear–positive and –negative specimens. In addi-
tion, the liquid culture system showed similar results for drug 
susceptibility testing against the first-line drugs, INH and RIF, 
compared with drug susceptibility testing using M-KIT plates. 
The recovery rates of Mtb isolates in the BacT Alert 3D system 
was slightly higher than that in the LJ medium, albeit without 
statistical significance (p=0.34). These results were consistent 
with previously published studies17,18, but our recovery rates 
were slightly higher19,20.
The agreement rates of drug susceptibility testing between 
the M-KIT plates and the BacT Alert 3D system were 97.7% 
(kappa coefficient, 0.905) and 98.6% (kappa coefficient, 0.907) 
for INH and RIF, respectively (Table 5). These results indicate 
no difference in drug susceptibility testing against INH or 
RIF using the M-KIT plates versus the BacT Alert 3D system. 
These results were in accordance with previous reports21,22. In 
addition, the majority of drug-resistant Mtb isolates showed 
INH or RIF-related resistance. Only 17.2% of Mtb isolates were 
INH mono-resistant or INH and RIF dual-resistant, while the 
remaining Mtb isolates (82.8%) showed resistance against 
other first-line drugs (EMB, PZA) or six second-line drugs. 
These observations indicated that drug susceptibility testing 
against INH and RIF is essential, but that testing for the re-
maining drugs should not be excluded. 
The liquid culture system has advantages in reducing the 
mycobacterial culture period and drug susceptibility testing. 
However, the results of drug susceptibility testing using the 
liquid culture system did show good concordance with that 
using solid medium for some drugs, such as EMB, SM, and 
KM. Although drug susceptibility testing using solid medium 
requires a longer culture time, it can be performed simultane-
ously for all target drugs in the case of the absolute concentra-
tion method using M-KIT plates. Therefore, drug susceptibility 
testing using liquid culture systems must be optimized further 
for other anti-TB drugs, but the combination of solid and liquid 
culture systems should be considered for effective and eco-
nomic mycobacterial culture and drug susceptibility testing, 
especially in situations with a high burden of drug resistance. 
In conclusion, the BacT Alert 3D system, a liquid culture 
system, showed superiority in reducing the culture period 
compared with the solid medium culture method, but drug 
susceptibility testing using M-KIT plates still has advantages 
for simultaneous testing against multiple drug targets, espe-
cially in the cases of MDR-TB and XDR-TB high burdens.
Table 5. Results of drug susceptibility testing of Mycobacterium tuberculosis isolates for INH and RIF using LJ medium and 
the BacT Alert 3D system
Drug resistance
INH (n=217) RIF (n=217)
LJ media BacT Alert 3D system
Sensitive Sensitive 184 (84.8) 198 (91.2)
Resistant Resistant 28 (12.9) 16 (7.4)
Resistant Sensitive 2 (0.9) 0 (0)
Sensitive Resistant 3 (1.4) 3 (1.4)
Agreement, % 97.7 98.6
Values are presented as number (%).
INH: isoniazid; RIF: rifampin; LJ medium: Löwenstein-Jensen medium.
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